The prediction of interaction sites between circular RNA (circRNA) and RNA binding proteins (RBPs) is crucial for regulating diseases and discovering new treatment approaches. Computational models have been widely used to predict circRNA-RBP interaction sites due to the availability of genome-wide circRNA binding event data. However, efficiently obtaining multi-scale circRNA features to improve prediction accuracy remains a challenging problem. In this study, we propose SSCRB, a lightweight model for predicting circRNA-RBP interaction sites. Our model extracts both sequence and structural features of circRNA and incorporates multi-scale features through the attention mechanism. Furthermore, we develop an ensemble model by combining multiple submodels to enhance predictive performance and generalizability. We evaluate SSCRB on 37 circRNA datasets and compare it with other state-of-the-art methods. The average AUC of SSCRB is 97.66%, demonstrating its efficiency and robustness. SSCRB outperforms other methods in terms of prediction accuracy while requiring significantly fewer computational resources. The codes and datasets are available online at https://github.com/zhaoqi106/SSCRB .

The prediction of drug-target affinity (DTA) plays a crucial role in drug development and the identification of potential drug targets. In recent years, computer-assisted DTA prediction has emerged as a significant approach in this field. In this study, we propose a multi-modal deep learning framework called MMD-DTA for predicting drug-target binding affinity and binding regions. The model can predict DTA while simultaneously learning the binding regions of drug-target interactions through unsupervised learning. To achieve this, MMD-DTA first uses graph neural networks and target structural feature extraction network to extract multi-modal information from the sequences and structures of drugs and targets. It then utilizes the feature interaction and fusion modules to generate interaction descriptors for predicting DTA and interaction strength for binding region prediction. Our experimental results demonstrate that MMD-DTA outperforms existing models based on key evaluation metrics. Furthermore, external validation results indicate that MMD-DTA enhances the generalization capability of the model by integrating sequence and structural information of drugs and targets. The model trained on the benchmark dataset can effectively generalize to independent virtual screening tasks. The visualization of drug-target binding region prediction showcases the interpretability of MMD-DTA, providing valuable insights into the functional regions of drug molecules that interact with proteins

The prediction of drug–target interaction (DTI) is crucial to drug discovery. Although the interactions between the drug and target can be accurately verified by traditional biochemical experiments, the determination of DTI through biochemical experiments is a time-consuming, laborious, and expensive process. Therefore, we propose a learning-based framework named BG-DTI for drug–target interaction prediction. Our model combines two main approaches based on biological features and heterogeneous networks to identify interactions between drugs and targets. First, we extract original features from the sequence to encode each drug and target. Later, we further consider the relationships among various biological entities by constructing drug–drug similarity networks and target–target similarity networks. Furthermore, a graph convolutional network and a graph attention network in the graph representation learning module help us learn the features representation of drugs and targets. After obtaining the features from graph representation learning modules, these features are combined into fusion descriptors for drug–target pairs. Finally, we send the fusion descriptors and labels to a random forest classifier for predicting DTI. The evaluation results show that BG-DTI achieves an average AUC of 0.938 and an average AUPR of 0.930, which is better than those of five existing state-of-the-art methods. We believe that BG-DTI can facilitate the development of drug discovery or drug repurposing.

A discrete‐time Geo/G/1 queue with vacations in random environment is analyzed. Using the method of supplementary variable, we give the probability generating function (PGF) of the stationary queue length distribution at arbitrary epoch. The PGF of the stationary sojourn time distribution is also derived. And we present the various performance measures such as mean number of customers in the system, mean length of the type‐i cycle, and mean time that the system resides in phase 0. In addition, we show that the M/G/1 queue with vacations in random environment can be approximated by its discrete‐time counterpart. Finally, we present some special cases of the model and numerical examples.